Hawaii SR 172: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN OR DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Status: Certified copies of resolutions sent, 06-21-21. (as of 2021-06-21)

State: Hawaii · Session: 2021 Regular Session · Bill: SR 172

Subjects: Department of Health, Medicinal Psilocybin and Psilocin Working Group

Sponsors: CHANG, GABBARD, LEE, Wakai

View Hawaii SR 172 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.